52064 Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondents Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Focus Groups ................................... General Public .................................. 45 1 1 45 

Interviews .......................................... General Public .................................. 45 1 1 45 

Pre/Post Tests .................................. General Public .................................. 3,500 2 15/60 1,750 

Pre/Post Tests .................................. Health Professionals ........................ 20,000 2 15/60 10,000 

Surveys ............................................. Health Professionals ........................ 2,000 1 30/60 1,000 

Tracking/Feedback Form .................. Health Educators .............................. 40 2 1 80 

Total ........................................... ........................................................... 25,630 49,170 ........................ 12,920 

Dated: November 2, 2017. 

Jennifer Guimond, 

Project Clearance Liaison, Eunice Kennedy 

Shriver National Institute of Child Health and 

Human Development, National Institutes of 

Health. 

[FR Doc. 2017–24399 Filed 11–8–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Toxicology Program Board of 

Scientific Counselors; Announcement 

of Meeting; Request for Comments 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the National Toxicology 

Program (NTP) Board of Scientific 

Counselors (BSC). The BSC, a federally 

chartered, external advisory group 

composed of scientists from the public 

and private sectors, will review and 

provide advice on programmatic 

activities. The meeting is open to the 

public and registration is requested for 

both attendance and oral comment and 

required to access the webcast. 

Information about the meeting and 

registration are available at http://

ntp.niehs.nih.gov/go/165. 

DATES:

Meeting: December 7–8, 2017; Day 

one begins at 8:30 a.m. Eastern Standard 

Time (EST) and ends at approximately 

5:00 p.m. Day 2 begins at 8:30 a.m. and 

continues until adjournment. 

Written Public Comment 

Submissions: Deadline is November 30, 

2017. 

Oral Comments: Deadline is 

November 30, 2017. 

Registration for Meeting: Deadline 

December 8, 2017. 

Registration to view the meeting via 

the webcast is required. 

ADDRESSES: 

Meeting Location: Rodbell 

Auditorium, Rall Building, National 

Institute of Environmental Health 

Sciences (NIEHS), 111 T.W. Alexander 

Drive, Research Triangle Park, NC 

27709. 

Meeting Web page: The preliminary 

agenda, registration, and other meeting 

materials are at http://ntp.niehs.nih.gov/ 

go/165. 

Webcast: The meeting will be 

webcast; the URL will be provided to 

those who register for viewing. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Mary Wolfe, Designated Federal Officer 

for the BSC, Office of Liaison, Policy 

and Review, Division of NTP, NIEHS, 

P.O. Box 12233, K2–03, Research 

Triangle Park, NC 27709. Phone: 984– 

287–3209, Fax: 301–451–5759, Email: 

wolfe@niehs.nih.gov. Hand Deliver/ 

Courier address: 530 Davis Drive, Room 

K2130, Morrisville, NC 27560. 

SUPPLEMENTARY INFORMATION: 

Meeting and Registration: The 

meeting is open to the public with time 

scheduled for oral public comments; 

attendance at the meeting is limited 

only by the space available. The BSC 

will provide input to the NTP on 

programmatic activities and issues. 

Preliminary agenda topics include: US 

Strategic Roadmap: New Approaches to 

Evaluate the Safety of Chemicals and 

Medical Products; NTP Assessing 

Alternative Approaches; New 

Approaches to Hazard Characterization 

and Risk Assessment; Update on NTP 

Studies of Glyphosate; and Report on 

Peer Review of Draft Report on 

Carcinogens Monograph on Haloacetic 

Acids. Please see the preliminary 

agenda for information about the 

specific presentations. The preliminary 

agenda, roster of BSC members, 

background materials, public comments, 

and any additional information, when 

available, will be posted on the BSC 

meeting Web site (http://

ntp.niehs.nih.gov/go/165) or may be 

requested in hardcopy from the 

Designated Federal Official for the BSC. 

Following the meeting, summary 

minutes will be prepared and made 

available on the BSC meeting Web site. 

The public may attend the meeting in 

person or view the webcast. Registration 

is required to view the webcast; the URL 

for the webcast will be provided in the 

email confirming registration. 

Individuals who plan to provide oral 

comments (see below) are encouraged to 

register online at the BSC meeting Web 

site (http://ntp.niehs.nih.gov/go/165) by 

November 30, 2017, to facilitate 

planning for the meeting. Individuals 

are encouraged to access the Web site to 

stay abreast of the most current 

information regarding the meeting. 

Visitor and security information for 

those attending in-person is available at 

niehs.nih.gov/about/visiting/index.cfm. 

Individuals with disabilities who need 

accommodation to participate in this 

event should contact Ms. Robbin Guy at 

phone: (984) 287–3136 or email: guyr2@

niehs.nih.gov. TTY users should contact 

the Federal TTY Relay Service at 800– 

877–8339. Requests should be made at 

least five business days in advance of 

the event. 

Request for Comments: Written 

comments submitted in response to this 

notice should be received by November 

30, 2017. Comments will be posted on 

the BSC meeting Web site and persons 

submitting them will be identified by 

their name and affiliation and/or 

sponsoring organization, if applicable. 

Persons submitting written comments 

should include their name, affiliation (if 

applicable), phone, email, and 

sponsoring organization (if any) with 

the document. Guidelines for public 

comments are at http://

ntp.niehs.nih.gov/ntp/about_ntp/ 

guidelines_public_comments_508.pdf. 

Time is allotted during the meeting 

for the public to present oral comments 

to the BSC on the agenda topics. Public 

comments can be presented in-person at 

the meeting or by teleconference line. 

There are 50 lines for this call; 

availability is on a first-come, firstserved basis. The lines will be open 

from 8:30 a.m. until adjournment, 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices 52065 

although the BSC will receive public 

comments only during the formal public 

comment periods, which are indicated 

on the preliminary agenda. Each 

organization is allowed one time slot 

per agenda topic. Each speaker is 

allotted at least 7 minutes, which if time 

permits, may be extended to 10 minutes 

at the discretion of the BSC chair. 

Persons wishing to present oral 

comments should register on the BSC 

meeting Web site by November 30, 

2017, indicate whether they will present 

comments in-person or via the 

teleconference line, and indicate the 

topic(s) on which they plan to comment. 

The access number for the 

teleconference line will be provided to 

registrants by email prior to the meeting. 

On-site registration for oral comments 

will also be available on the meeting 

day, although time allowed for 

comments by these registrants may be 

limited and will be determined by the 

number of persons who register at the 

meeting. 

Persons registering to make oral 

comments are asked to send a copy of 

their statement and/or PowerPoint 

slides to the Designated Federal Officer 

by November 30, 2017. Written 

statements can supplement and may 

expand upon the oral presentation. If 

registering on-site and reading from 

written text, please bring 20 copies of 

the statement for distribution to the BSC 

and NTP staff and to supplement the 

record. 

Background Information on the BSC: 

The BSC is a technical advisory body 

comprised of scientists from the public 

and private sectors that provides 

primary scientific oversight to the NTP. 

Specifically, the BSC advises the NTP 

on matters of scientific program content, 

both present and future, and conducts 

periodic review of the program for the 

purpose of determining and advising on 

the scientific merit of its activities and 

their overall scientific quality. Its 

members are selected from recognized 

authorities knowledgeable in fields such 

as toxicology, pharmacology, pathology, 

biochemistry, epidemiology, risk 

assessment, carcinogenesis, 

mutagenesis, molecular biology, 

behavioral toxicology, neurotoxicology, 

immunotoxicology, reproductive 

toxicology or teratology, and 

biostatistics. Members serve overlapping 

terms of up to four years. The BSC 

usually meets biannually. The authority 

for the BSC is provided by 42 U.S.C. 

217a, section 222 of the Public Health 

Service Act (PHS), as amended. 

The BSC is governed by the 

provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: November 1, 2017. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2017–24401 Filed 11–8–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

joint meeting of the NCI Board of 

Scientific Advisors (BSA) and National 

Cancer Advisory Board (NCAB). 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http://

videocast.nih.gov). 

A portion of the National Cancer 

Advisory Board meeting will be closed 

to the public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended, 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Cancer Institute, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board, Ad Hoc Subcommittee on 

Global Cancer Research. 

Open: November 28, 2017, 5:30 p.m. to 

7:00 p.m. 

Agenda: Discussion on Global Cancer 

Research. 

Place: Gaithersburg Marriott 

Washingtonian Center, Lakeside Conference 

Room 1 and 2, 9751 Washington Boulevard, 

Gaithersburg, MD 20878. 

Contact Person: Dr. Edward Trimble, 

Executive Secretary, NCAB Ad Hoc 

Subcommittee on Global Cancer Research, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, Room 3W562, Bethesda, MD 

20892, (240) 276–5796, trimblet@

mail.nih.gov. 

Name of Committee: National Cancer 

Advisory Board, Ad Hoc Subcommittee on 

Population Science, Epidemiology and 

Disparities. 

Open: November 28, 2017, 7:30 p.m. to 

9:00 p.m. 

Agenda: Discussion on Population Science, 

Epidemiology and Disparities. 

Place: Gaithersburg Marriott 

Washingtonian Center, Lakeside Conference 

Room 1 and 2, 9751 Washington Boulevard, 

Gaithersburg, MD 20878. 

Contact Person: Dr. Deborah Winn, 

Executive Secretary, NCAB Ad Hoc 

Subcommittee on Population Science, 

Epidemiology and Disparities, National 

Cancer Institute—Shady Grove, National 

Institutes of Health, 9609 Medical Center 

Drive, Room 4E344, Bethesda, MD 20892, 

(240) 276–6755, winnde@mail.nih.gov. 

Name of Committee: NCI Board of 

Scientific Advisors and National Cancer 

Advisory Board. 

Open: November 29, 2017, 8:30 a.m. to 

4:00 p.m. 

Agenda: Joint meeting of the NCI Board of 

Scientific Advisors and National Cancer 

Advisory Board; NCI Director’s report and 

presentations, NCI Board of Scientific 

Advisors Concepts Review. 

Closed: November 29, 2017, 4:30 p.m. to 

5:30 p.m. 

Agenda: Review of intramural program site 

visit outcomes and the discussion of 

confidential personnel issues. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Room 

TE406 & 408, Rockville, MD 20850. 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, Room 7W444, Bethesda, MD 

20892, 240–276–6340, grayp@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NCI-Shady Grove campus. All 

visitors will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: NCAB: http:// 

deainfo.nci.nih.gov/advisory/ncab/ncab.htm, 

BSA: http://deainfo.nci.nih.gov/advisory/bsa/ 

bsa.htm, where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


sradovich on DSK3GMQ082PROD with NOTICES